As of November 20, 2009

• Established Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2010 (November 20, 2009)

As of November 18, 2009

• Proposed Rule - Placement of Carisoprodol Into Schedule IV (November 17, 2009)

As of November 16, 2009

• 30-day notice of information collection under review. Proposed Collection; Comments Requested: Collection of Laboratory Analysis Data on Drug Samples Tested by Non-Federal (State and Local) Crime Laboratories (November 16, 2009)

• 30-day notice of information collection under review. Proposed Collection; Comments Requested: Annual Reporting Requirement for Manufacturers of Listed Chemicals (November 16, 2009)

• 30-day notice of information collection under review. Proposed Collection; Comments Requested: Report of Mail Order Transaction (November 16, 2009)

As of November 12, 2009

• Boehringer Ingelheim Chemicals, Inc (November 12, 2009)

• Stepan Company (November 12, 2009)

• Noramco Inc (November 12, 2009)

As of November 10, 2009

• National Drug Code Dictionary

As of November 6, 2009

• ISP Freetown Fine Chemicals (November 6, 2009)

• Boehringer Ingelheim Chemicals, Inc. (November 6, 2009)
• Stepan Company (November 6, 2009)

As of October 29, 2009

• Johnson Matthey, Inc. (October 29, 2009)

As of October 28, 2009

• Registration Requirements for Individual Practitioners Operating in a "Locum Tenens" Capacity (October 28, 2009)

• Proposed Rule - Placement of 5-Methoxy-N,N- Dimethyltryptamine Into Schedule I of the Controlled Substances Act (October 28, 2009)

• Clinical Supplies Management (October 28, 2009)

• Formulation Technologies LLC (October 28, 2009)

• Cerilliant Corporation (October 28, 2009)

• Hospira Inc (October 28, 2009)

• Cody Laboratories Inc (October 28, 2009)

• Mylan Technologies Inc (October 28, 2009)
• Noramco, Inc. (October 28, 2009)
• Archimica, Inc. (October 28, 2009)
• Mylan Pharmaceuticals Inc. (October 28, 2009)

• Archimica, Inc. (October 28, 2009)

• Johnson Matthey Inc (October 28, 2009)

• Cayman Chemical Company (October 28, 2009)

• Varian, Inc (October 28, 2009)

• Aldrich Chemical Company Inc., DBA Isotec (October 28, 2009)

• Lonza Riverside (October 28, 2009)

• Lin Zhi International Inc. (October 28, 2009)

• American Radiolabeled Chemical, Inc (October 28, 2009)

• Chattem Chemicals Inc. (October 28, 2009)

• Chattem Chemicals Inc. (October 28, 2009)

• Organix Inc. (October 28, 2009)

• Noramco Inc. (October 28, 2009)

• Wildlife Laboratories Inc. (October 28, 2009)

• Siegfried (USA), Inc. (October 28, 2009)

• Austin Pharma LLC (October 28, 2009)

As of October 26, 2009

• Samuel H. Albert, M.D.; Dismissal of Proceeding (October 23, 2009)
• Established Initial Aggregate Production Quotas for 2010 (October 21, 2009)
• Final Revised Aggregate Production Quotas for 2009 (October 21, 2009)

As of October 20, 2009

• 60-Day Notice of Information Collection Under Review. Proposed Collection; Comments Requested: Reporting and Recordkeeping for Digital Certificates (October 20, 2009)